Dividend stocks can make you rich. It's as simple as that. While they don't garner the notability of high-flying growth stocks, they're also less likely to crash and burn. And over the long term, the compounding effect of the quarterly payouts, as well as their growth, adds up faster than most investors imagine.
In fact, a study by C. Thomas Howard published in Advisor Perspectives found that for every percentage point a stock's yield rises, its annual return increases by 0.22 percentage points if it's a large cap, 0.25 if it's a mid cap, and 0.46 if it's a small cap. Even better, Howard found that dividend-growing stocks outperformed dividend cutters by 10 percentage points per year from 1973 to 2010 and beat both flat- and no-dividend stocks. And the icing on the cake is that Howard showed that this outperformance came with a third less volatility. Higher returns, less volatility-induced stress, and a steadily growing income stream -- three powerful aspects of dividend growth investing that can help you grow your wealth.
Top Sliver Companies To Watch In Right Now: Tim Hortons Inc.(THI)
Tim Hortons Inc. develops, franchises, and operates quick service restaurants primarily in Canada and the United States. Its restaurants serve coffee and other hot and cold beverages, baked goods, sandwiches, soups, and other food products. As of April 03, 2011, the company and its restaurant owners operated 3,169 restaurants in Canada and 613 restaurants in the United States under the Tim Hortons name; and had 274 primarily self-serve licensed locations in the Republic of Ireland and the United Kingdom Tim Hortons Inc. was founded in 1964 and is based in Oakville, Canada.
Advisors' Opinion:- [By Eric Volkman]
Tim Hortons (NYSE: THI ) will have a new nameplate on the door of its chief executive's office starting this summer. The company announced that it has named Marc Caira as CEO, effective July 2. He succeeds Paul House, who will remain in his post as chairman of the board.
- [By Ben Levisohn]
Burger King Worldwide (BKW) has risen 3.2% to $33.45 after Warren Buffett said he would help finance its merger with Tim Hortons (THI). Tim Hortons has leaped 10% to $82.55.
Top 10 Mid Cap Companies To Own For 2015: LifePoint Hospitals Inc.(LPNT)
LifePoint Hospitals Inc., through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States. The company?s hospitals provide a range of medical and surgical services comprising general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services, and pediatric services, as well as specialized services, such as open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. Its hospitals also offer outpatient services, including one-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. As of December 31, 2009, LifePoint Hospitals owned or leased 47 hospitals with a total of 5,552 licensed beds in 17 states. The company was founded in 1997 and is headquartered in Brentwood, Tennessee. Lifepoint Hospitals Inc. (NasdaqNM:LPNT) operates independently of HCA Inc. as of May 11, 1999.
Advisors' Opinion:- [By Keith Speights]
The fun wasn't just limited to the big three hospital operators. Lifepoint Hospitals (NASDAQ: LPNT ) stock jumped 5% on the CMS news, reflecting a $109 million market cap expansion. Likewise, Vanguard Health Systems (NYSE: VHS ) shares climbed 5%, bumping its market cap up by�$55 million.
- [By Ben Levisohn]
Yesterday afternoon, Pennsylvania announced that it would use federal dollars to pay private insurers to cover eligible Pennsylvanians. UBS analysts A.J. Rice and Jailendra Singh think Community Health Systems (CYH), Tenet Healthcare (THC) and LifePoint Hospitals (LPNT) stand to benefit the most from the deal:
Top 10 Mid Cap Companies To Own For 2015: Repros Therapeutics Inc.(RPRX)
Repros Therapeutics Inc., a development stage biopharmaceutical company, focused on the development of new drugs to treat hormonal and reproductive system disorders. It is developing Androxal, an oral therapy that normalizes testicular function for the treatment of low testosterone due to secondary hypogonadism. The company is also conducting a phase 2 study of the use of Androxal in the treatment of type 2 diabetes in hypogonadal men. In addition, it is developing Proellex, an orally administered selective blocker of the progesterone receptor in women for the treatment of uterine fibroids and endometriosis; and phentolamine-based product candidate VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics, Inc. in May 2006. Repros Therapeutics, Inc. was founded in 1987 and is based in The Woodlands, Texas.
Advisors' Opinion:- [By Lisa Levin]
Repros Therapeutics (NASDAQ: RPRX) moved up 26.15% to $26.82 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐.
- [By Lauren Pollock]
Repros Therapeutics Inc.(RPRX) pushed back its planned new drug application for its low-testosterone treatment, following a request from the U.S. Food and Drug Administration to discuss recent trial data. The company now expects to submit its new drug application for Androxal in the second half of next year. Shares were down 30% at $16.70 premarket.
- [By Jake L'Ecuyer]
Equities Trading UP
Repros Therapeutics (NASDAQ: RPRX) shot up 29.82 percent to $27.60 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐. Shares of Kythera Biopharmaceuticals (NASDAQ: KYTH) got a boost, shooting up 26.04 percent to $42.26 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Aeropostale (NYSE: ARO) was also up, gaining 16.75 percent to $10.05 after private equity firm Sycamore Partners reported that it had bought a 7.96 percent stake in the company. - [By Rich Bieglmeier]
In the movie business, they call this foreshadowing. You would have made a killing if you did nothing else but ride piggy-back when Repros Therapeutics Inc.'s (RPRX) Ms. Katherine A. Anderson opened the checkbook. She might not be a big buyer, but whoa, it's no doubt that the CPA and Chief Financial Officer, Chief Accounting Officer and Secretary knows how to work the numbers.
Top 10 Mid Cap Companies To Own For 2015: Fastenal Company(FAST)
The Company Is Engaged As A Wholesaler And Retailer Of Industrial And Construction Supplies. The Industrial And Construction Supplies Were Grouped Into Ten Product Lines: Fasteners, Tools And EquipmeNt, Cutting Tools And Abrasives, Hydraulics, Pneumatics, Plumbing And Hvac, Material Handling, Storage And Packaging, Janitorial Supplies, Chemicals And Paints, Electrical Supplies, Welding Supplies, Safety Supplies And Metals, Alloys And Materials.
Advisors' Opinion:- [By Chris Hill]
In this installment, our analysts discuss four stocks making big moves.�CarMax (NYSE: KMX ) hits an all-time high after fourth-quarter profits rise. PriceSmart (NASDAQ: PSMT ) jumps after the retailer reports better-than-expected results. Fastenal (NASDAQ: FAST ) falls after it reports weaker-than-expected revenues. And 3D Systems (NYSE: DDD ) racks up big gains after one of its competitors gets an upgrade.�
- [By Shauna O'Brien]
Shares of Fastenal Company (FAST) were down nearly 3% on Wednesday morning after the company reported earnings that fell below analysts’ expectations.�
FAST’s Earnings in Brief
FAST reported Q4 earnings of�$99.23 million, or 33 cents per share, up from $98.72 million, or 32 cents per share, a year ago. Total revenue was�$813.76 million, up from $757.24 last year. On average, analysts expected to see earnings of 34 cents with�$813.25 million in revenue. For FY2013, the company reported�$448.64 million or $1.51 per share in earnings, up from $420.54 million in 2012. Analysts expected to see earnings per share of $1.52. Revenue for the year was $3.33 billion, up from $3.13 billion in 2012. Analysts expected to see revenue of $3.33 billion.FAST’s Dividend Announcement
On Tuesday, FAST declared its next 25 cent quarterly dividend. This dividend will be paid on February 28 to shareholders of record on January 31. The stock will go ex-dividend on January 29.
Stock Performance
Fastenal shares were down $1.27, or 2.63% during pre-market trading
Top 10 Mid Cap Companies To Own For 2015: iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD)
iShares iBoxx $ InvesTop Investment Grade Corporate Bond Fund, formerly known as iShares GS $ InvesTop Corporate Bond Fund, seeks investment results that correspond generally to the price and yield performance of the corporate bond market as defined by the iBoxx $ Liquid Investment Grade Index (formerly the GS $ InvesTop Index) (the Index). The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index.
The Index measures the performance of a fixed number of highly liquid investment-grade corporate bonds. The Index is a rules-based index consisting of up to 100 highly liquid, investment-grade, United States dollar-denominated corporate bonds that seek to maximize liquidity while maintaining representation of the corporate bond market. The Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Eric Mancini]
A good example of this low duration advantage is 2013. The U.S. investment grade bond index, with the I-Shares Iboxx ETF (NYSE: LQD) as a reference, was down 2.2 percent on a total return basis, while the Chinese renminbi-denominated investment grade index, using the Power Shares Chinese Dim Sum ETF (NYSE: DSUM) as the proxy, was up 6.3 percent!
- [By Chuck Saletta]
Where to invest?
Domestic stocks. The Vanguard Total Market (NYSEMKT: VTI ) ETF is a one-stop-shop that gives you access to around 99.5% by market cap of the publicly held U.S. stocks traded on major exchanges. A mere 3% turnover and microscopically low 0.05% expense ratio makes this a low-cost way to invest in the overall stock market. Investment-grade bonds. The iShares iBoxx $Invest Grade Corp Bond � (NYSEMKT: LQD ) ETF owns nearly $24 billion worth of investment-grade corporate bonds. A small 4% turnover and low 0.15% expense ratio make this a low-cost way to get bond exposure. Real estate. The SPDR Dow Jones REIT (NYSEMKT: RWR ) ETF has a bit over $2 billion invested in real estate investment trusts, attempting to match the Dow Jones Select REIT index. With a reasonable 7% turnover and a still pretty low 0.25% expense ratio, this is a reasonable way to get real estate exposure without turning yourself into a landlord. Foreign stocks. Vanguard's Total International Stock Index (NASDAQ: VXUS ) ETF has nearly $90 billion in foreign stocks under its control, owning pieces of more than 6,100 stocks from 45 countries. With a mere 3% turnover and low 0.16% expense ratio, it's one of the lowest-cost ways to get your hands on foreign companies without being an international accounting expert. Inflation-protected government bonds. The iShares Barclays TIPS Bond (NYSEMKT: TIP ) ETF has around $20 billion invested in U.S. Treasury inflation-protected bonds. With a low expense ratio of 0.2% and a reasonable 10% turnover rate, it's a decent way to get exposure to inflation-protected bonds. Note, though, that
There are countless possibilities for building your retirement portfolio to cover Social Security's gap, depending on your personal risk tolerance, timeline, and need for cash. Here are decent index-style ETFs across various asset types to consider when building your plan:
Top 10 Mid Cap Companies To Own For 2015: Kronos Worldwide Inc (KRO)
Kronos Worldwide, Inc. engages in the production and marketing of titanium dioxide pigments (TiO2) primarily in Europe and North America. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for products, such as coatings, paints, plastics, papers fibers, and ceramics, as well as for various specialty products, including inks, food, and cosmetics. The company also offers ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are co-products and processed co-products of the TiO2 production process and used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; and titanium oxychloride and titanyl sulfate that are side-stream products from the production of TiO2. Its titanium oxychloride is used in the formulation of pearlescent pigments, production of electroceramic capacitors for cell phones, and other electronic devices; and titanyl sulfate is used in pearlescent pigments, natural gas pipe, and other specialty applications. In addition, the company provides technical services. Kronos Worldwide, Inc. sells its products through distributors and agents to paint, plastics, decorative laminate, and paper manufacturers under the Kronos brand name. The company was founded in 1989 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.
Advisors' Opinion:- [By Ben Levisohn]
Typically, when the chairman of a company dies, its shares drop. That hasn’t been the case for Valhi (VHI), Kronos Worldwide (KRO) and NL Industries (NL), which have all advanced today after Harold Simmons passed away.
- [By John Udovich]
Dallas billionaire Harold Simmons died over the weekend with investors sending shares of some of his publically traded companies like Valhi, Inc (NYSE: VHI), Kronos Worldwide, Inc (NYSE: KRO), NL Industries, Inc (NYSE: NL) and�CompX International Inc (NYSEMKT: CIX)to higher levels as they anticipate changes���such as asset sales or spin offs. Harold Simmons was the embodiment of the American dream because he was born during the depths of the Great Depression in Golden, Texas to schoolteacher parents and he spent�his early years living without indoor plumbing or electricity. However and by recognizing�underpriced assets and through the use of massive amounts of leverage (e.g. junk bonds),�he built an empire and�ranked #40 on the 2013 Forbes 400 with a fortune estimated to be worth some $10 billion.
- [By GuruFocus]
Kronos Worldwide Inc. (KRO): Vice Chairman of the Board and CEO Steven L. Watson Bought 14,250 Shares
Vice Chairman of the Board and CEO of Kronos Worldwide Inc. (KRO) Steven L. Watson bought 14,250 shares during the past week at an average price of $14.81. Kronos Worldwide Inc. is a Delaware Corporation. The company is a global producer and marketer of value-added titanium dioxide pigments (TiO2). Kronos Worldwide Inc. has a market cap of $1.72 billion; its shares were traded at around $14.81 with a P/E ratio of 42.60 and P/S ratio of 0.95. The dividend yield of Kronos Worldwide Inc. stocks is 4.05%. Kronos WorldwideInc. had an annual average earnings growth of 5.4% over the past 10 years.
- [By Laura Brodbeck]
Notable earnings releases expected on Thursday include:
Dollar General Corporation (NYSE: DG) is expected to report fourth quarter EPS of $1.02 on revenue of $4.63 billion, compared to last year�� EPS of $0.97 on revenue of $4.21 billion. Kronos Worldwide Inc (NYSE: KRO) is expected to report fourth quarter EPS of $0.01 on revenue of $371.45 million, compared to last year�� loss of $0.12 per share on revenue of $396.80 million. Christopher & Banks Corporation�(NYSE: CBK) is expected to report a fourth quarter loss of $0.03 on revenue of $106.64 million, compared to last year�� loss of $0.11 on revenue of $115.98 million.Economics
Top 10 Mid Cap Companies To Own For 2015: Solta Medical Inc(SLTM)
Solta Medical, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system for patients who want to take control of their aging process. The company also provides Thermage CPT system that provides non-invasive treatment options for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the tre atment of mild-to-moderate inflammatory acne, including pustular acne. Its customers principally include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. The company sells its products primarily through a direct sales force, as well as through independent distributors; and CLARO device through retail and associated retailer?s Websites, and television retail networks, as well as through its own website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.
Advisors' Opinion:- [By Tess Stynes]
Among the companies with shares expected to actively trade in Monday’s session are Sprint Corp.(S), American International Group Inc.(AIG)�and Solta Medical Inc.(SLTM)
No comments:
Post a Comment